FDA opens TAP

The US Food and Drug Administration (FDA) has initiated a soft launch of its Total Product Lifecycle Advisory Program (TAP), which was negotiated under the latest Medical Device User Fee Amendments (MDUFA V) deal. The agency has updated its website with details about how to apply for the pilot program and its plans to expand the program over the next five years.